Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Are The Future Growth Projections For The Intussusception Market Size?

The dimension of the intussusception market has seen a consistent expansion in the past few years. The forecast shows a surge from $4.45 billion in 2024 to $4.67 billion in 2025, indicating a compound annual growth rate (CAGR) of 4.8%. This progression throughout the historical phase can be credited to enhanced diagnostic proficiency, escalated consciousness and enlightenment, worldwide healthcare infrastructure escalation, an infusion of funds into research and development, and teamwork within healthcare bodies.

Expectations are set for the intussusception market size to steadily grow in the upcoming years. The projected expansion is up to $5.46 billion by 2029, at a compound annual growth rate (CAGR) of 4.0%. The anticipated growth for the forecast period is associated with ongoing initiatives in medical education, focus on postoperative care, pediatric vaccination programs, global pediatric healthcare efforts, growing demand for research in pediatric gastrointestinal studies, telehealth services, and accessibility to remote healthcare. Key trends to watch include advancements in diagnostic imaging technology, minimal invasive treatments, introduction of pediatric-specific interventions, studies on causative factors and risk, global epidemiological studies, application of vaccination programs, and the use of telemedicine for diagnosis and consultation.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13466&type=smp

Which Factors Are Steering Growth In The Intussusception Market?

The escalating rate of intestinal problems is predicted to boost the growth of the intussusception market in the future. The term intestinal disorders encompass all medical issues that affect the regular functioning of the intestines, a critical part of the digestive system responsible for nutrient absorption and waste elimination from the body. There is an upward trend of intestinal maladies like inflammatory bowel disease and gastrointestinal cancers. This trend tends to lead to early detection, improved therapeutic methods, and increased support for those suffering from intussusception, which can substantially improve their health and quality of life. For example, the American Cancer Society (ACS), a US health organization committed to eradicating cancer, disclosed in January 2023 that gastrointestinal cancers have risen by 3.18% to 348,840 from 338,090 in 2021 in the United States. Consequently, the increasing prevalence of intestinal health issues will push the growth of the intussusception market.

How Is The Intussusception Market Organized By Different Segments?

The intussusceptionmarket covered in this report is segmented –

1) By Type: Idiopathic Intussusception; Secondary Intussusception

2) By Treatment: Enema Reduction; Surgery; Other Treatment

3) By Diagnosis: Barium Enema; Ultrasound; X-Ray; Computerized Tomography (CT)

4) By End-User: Hospitals; Clinics; Other End-User

Subsegments:

1) By Idiopathic Intussusception: Childhood Idiopathic Intussusception; Adult Idiopathic Intussusception

2) By Secondary Intussusception: Neoplastic Intussusception; Infectious Intussusception; Inflammatory Intussusception; Post-Surgical Intussusception

What Current And Upcoming Trends Are Shaping The Intussusception Market?

Leading companies in the market for treatment of intestinal pseudo-obstruction are focusing on the creation of innovative drug therapies such as NHE3 inhibitor treatment therapy to offer reliable solutions for their clients. The NHE3 inhibitor treatment therapy is a drug that functions by restricting the Sodium-Proton-Exchanger subtype 3 (NHE3) in the intestine. As an illustration, Ardelyx Inc., a biopharmaceutical organization based in the US, launched IBSRELA, an NHE3 inhibitor-based treatment for adults suffering from irritable bowel syndrome with constipation (IBS-C), in April 2022. This may enhance gastrointestinal motility. The method of action for the IBSRELA treatment therapy is the restriction or blockade of the Sodium-Hydrogen Exchanger 3 (NHE3) protein. The approval of IBSRELA was grounded on the outcomes of two Phase 3 trials that encompassed more than 1,200 IBS-C patients, demonstrating significant amelioration in abdominal discomfort and bowel regularity. The primary endpoint was met, and improvement was noticeable as early as the first week, with the effects persisting for 26 weeks in the lengthy trial.

Who Are The Most Influential Companies In The Intussusception Market?

Major companies operating in the intussusception market report are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Abbott Laboratories, Sanofi S.A., GlaxoSmithKline PLC, Stryker Corporation, Boston Scientific Corporation, Biogen Inc., Olympus Corporation, GE HealthCare Technologies Inc., Steris PLC, Cook Medical LLC, Shimadzu Corporation, Carestream Health, CONMED Corporation, Janssen Pharmaceuticals Inc., EndoChoice Holdings Inc., Fujifilm Healthcare Solutions, Basilea Pharmaceutica Ltd., Richard Wolf GmbH, Karl Storz SE And Co. KG, Eizoflex Co. Ltd., Arena Pharmaceuticals Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/intussusception-global-market-report

Which Region Dominates The Intussusception Market Today?

North America was the largest region in the intussusception market in 2024. The regions covered in the intussusception market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=13466&type=smp

Browse Through More Reports Similar to the Global Intussusception Market 2025, By The Business Research Company

Neuralgia Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neuralgia-treatment-global-market-report

Pituitary Dwarf Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pituitary-dwarf-treatment-global-market-report

Tracheitis Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tracheitis-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model